This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Targetpharma Laboratories (Changzhou) Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Minjin Hu - Innovator in Annexin V Variants
Introduction
Minjin Hu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biochemistry, particularly through his work on annexin V variants. His innovative approach has led to advancements that are applicable in various industrial settings.
Latest Patents
Minjin Hu holds a patent for an "Annexin V variant and its preparation and application." This invention provides a detailed design, preparation methods, and applications of the annexin V variant. The variant is characterized by its amino acid residue sequence, which is derived from a specific sequence by substituting, missing, or adding one or several amino acid residues. The resulting protein maintains the same biological activity as the original sequence. The preparation methods yield a variant protein with high purity, productivity, labeling efficiency, and stability, making it suitable for industrial production and further research.
Career Highlights
Minjin Hu is currently associated with Targetpharma Laboratories (Changzhou) Co., Ltd. His work at this company has allowed him to focus on the practical applications of his research in the pharmaceutical industry. His dedication to innovation has positioned him as a key figure in his field.
Collaborations
Minjin Hu collaborates with Zichun Hua, contributing to the advancement of their shared research interests. Their partnership enhances the potential for breakthroughs in the development of annexin V variants.
Conclusion
Minjin Hu's contributions to the field of biochemistry, particularly through his patent on annexin V variants, highlight his innovative spirit and dedication to research. His work not only advances scientific knowledge but also has practical applications in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile